Transgenomic Inc (TBIO) - Medical Equipment - Deals and Alliances Profile

Date: January 25, 2017
Pages: 52
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: T3CEAB02BD5EN
Leaflet:

Download PDF Leaflet

Transgenomic Inc (TBIO) - Medical Equipment - Deals and Alliances Profile
Summary

Transgenomic Inc (Transgenomic) is a biotechnology company that offers personalized medicine in oncology, cardiology, neurology, and inherited diseases. The company’s products include ICEme Kits, and genetic assays and platforms. Its offers genetic assays and platforms such as chromatography, hanabi cytogenetic systems, genetic analysis kits, PCR reagents, tissue microarray platforms and WAVE DHPLC systems. Transgenomic provides specimen collection kits which include cardiology kits, neurology kits, oncology kits, pharmacogenomic kits, scoliscore AIS prognostic kits and Whole Exome sequencing kits. The company offers patient testing services for cardiology, neurology, mitochondrial disorders and oncology. Transgenomic is headquartered in Omaha, Nebraska, the US.

Transgenomic Inc (TBIO) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Transgenomic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Transgenomic Inc, Medical Equipment Deals By Type, 2011 to YTD 2017
Transgenomic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
Transgenomic Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017
Transgenomic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017
Transgenomic Inc, Medical Equipment, Deal Details
Asset Purchase
Transgenomic Completes Acquisition Of Rights To Scoliscore AIS Prognostic Test From Axial Biotech For US$4 Million
Partnerships
LifeLabs Enters into Licensing Agreement with Transgenomic
University of Melbourne Enters into Licensing Agreement with Transgenomic
Transgenomic Expands Licensing Agreement with Dana-Farber Cancer Institute for Multiplexed Ice cold-PCR Technlogy
Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test
Transgenomic Expands Exclusive Licensing Agreement With Dana-Farber Cancer Institute
Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio
Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test
Transgenomic Enters Into Distribution Agreement With ScreenCell
Transgenomic Enters Into Distribution Agreement With A. Menarini Diagnostics
Transgenomic Expands Licensing Agreement with Exiqon
Transgenomic Enters Into Licensing Agreement With Montefiore Medical
Equity Offering
Transgenomic to Raise up to USD7 Million in Private Placement of Shares
Transgenomic to Raise up to USD3.5 Million in Public Offering of Shares
Transgenomic Raises up to USD2.2 Million in Private Placement of Preferred Stock and Warrant
Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants
Transgenomic Raises USD7 Million in Private Placement of Shares
Transgenomic Completes Private Placement Of Shares For US$8 Million
Transgenomic Completes Private Placement Of Shares For US$19 Million
Asset Transactions
ADSTEC Acquires Genetic Assays & Platforms Business Unit from Transgenomic
Edge Biosystems Acquires Ion Chromatography Product Line and Related Assets from Transgenomic for USD2 Million
Integrated DNA Technologies Acquires Rights to Surveyor Mutation Detection Technology and Assets from Transgenomic for up to USD4.25 Million
Acquisition
Transgenomic to Acquire Precipio Diagnostics
Transgenomic Inc - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
Aug 12, 2016: Transgenomic Reports Second Quarter 2016 Financial Results
May 24, 2016: Transgenomic Reports First Quarter 2016 Financial Results
Apr 14, 2016: Transgenomic Reports Full Year 2015 Financial Results
Legal and Regulatory
Mar 09, 2016: Ground-breaking settlement changes landscape for genetic medicine in Canada
Product News
Mar 18, 2016: Transgenomic Launches First Commercially Available Assay for Ultra Low Level Detection of EGFR C797S Mutations that Predict Resistance to Third Generation Kinase Therapies for Lung Cancer
Mar 10, 2016: Transgenomic Launches New MX-ICP Liquid Biopsy Test for Comprehensive Detection of Colorectal Tumor Mutations
Mar 10, 2016: Transgenomic Launches New MX-ICP Liquid Biopsy Test for Comprehensive Detection of Melanoma Tumor Mutations
Other Significant Developments
Sep 29, 2016: Transgenomic Adds New Distributors in China and India for its ICEme Kits that Enable Liquid Biopsy Cancer Testing on Existing Platforms
Aug 08, 2016: VWR to Distribute Transgenomic’s ICEme Kits That Enable Liquid Biopsy-Based Cancer Research on Existing Platforms
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES

Transgenomic Inc, Medical Equipment, Key Facts, 2015
Transgenomic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017
Transgenomic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Transgenomic Inc, Medical Equipment Deals By Type, 2011 to YTD 2017
Transgenomic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
Transgenomic Inc, Deals By Market, 2011 to YTD 2017
Transgenomic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017
Transgenomic Completes Acquisition Of Rights To Scoliscore AIS Prognostic Test From Axial Biotech For US$4 Million
LifeLabs Enters into Licensing Agreement with Transgenomic
University of Melbourne Enters into Licensing Agreement with Transgenomic
Transgenomic Expands Licensing Agreement with Dana-Farber Cancer Institute for Multiplexed Ice cold-PCR Technlogy
Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test
Transgenomic Expands Exclusive Licensing Agreement With Dana-Farber Cancer Institute
Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio
Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test
Transgenomic Enters Into Distribution Agreement With ScreenCell
Transgenomic Enters Into Distribution Agreement With A. Menarini Diagnostics
Transgenomic Expands Licensing Agreement with Exiqon
Transgenomic Enters Into Licensing Agreement With Montefiore Medical
Transgenomic to Raise up to USD7 Million in Private Placement of Shares
Transgenomic to Raise up to USD3.5 Million in Public Offering of Shares
Transgenomic Raises up to USD2.2 Million in Private Placement of Preferred Stock and Warrant
Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants
Transgenomic Raises USD7 Million in Private Placement of Shares
Transgenomic Completes Private Placement Of Shares For US$8 Million
Transgenomic Completes Private Placement Of Shares For US$19 Million
ADSTEC Acquires Genetic Assays & Platforms Business Unit from Transgenomic
Edge Biosystems Acquires Ion Chromatography Product Line and Related Assets from Transgenomic for USD2 Million
Integrated DNA Technologies Acquires Rights to Surveyor Mutation Detection Technology and Assets from Transgenomic for up to USD4.25 Million
Transgenomic to Acquire Precipio Diagnostics
Transgenomic Inc, Key Competitors
Transgenomic Inc, Key Employees
Transgenomic Inc, Other Locations
Transgenomic Inc, Subsidiaries 39

LIST OF FIGURES

Transgenomic Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017
Transgenomic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Transgenomic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
Transgenomic Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017
Transgenomic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Transgenomic Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017
Transgenomic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
Transgenomic Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017
Skip to top


Ask Your Question

Transgenomic Inc (TBIO) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: